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Host defence peptides are ubiquitous components of innate immunity within all living 
organisms. These peptides are small, positively charged and amphiphilic molecules. The 
biological roles of these peptides are direct antimicrobial activity against pathogens and 
to induce the innate and adaptive immune response within the host. 
The research presented in this thesis was focused on isolating host defence peptides 
from ostrich blood and characterising their antimicrobial properties. Four ostrich 
P-defensins, named ostricacins-1-4 (Osp-1-4), were successfully purified from ostrich 
blood. These peptides contained 36-42 amino acid residues, with the main residues 
including: arginines, lysines, glycines and cysteines. The molecular weight of these four 
ostricacins ranged between 4-5 k.Da . They displayed antimicrobial activity against 
Gram-negative bacteria and Gram-positive bacteria with minimum inhibitory 
concentration (M[C), ranging between 1-12 µg/ml. [n addition, Osp-2 displayed 
antimicrobial activity against yeast, with M[C of 6.2 µg/ml. Osp-1 and Osp-2 were 
further characterised with the investigation of the effects of cationic ions and 
temperature changes on their antimicrobial activity against Gram-negative bacteria and 
Gram-posit ive bacteria. The antimicrobial activity of both peptides significantly 
declined with the presence of cationic ions. Both peptides were relatively stable when 
heated to temperatures between 30-70°C. Finally, an investigation of the mode of action 
of Osp-1 and Osp-2 against Gram-negative bacteria was carried out. Both peptides were 
compared with a sheep cathclicidin, SMAP-29, and a human a-defensin, HNP-1. 
SMAP-29 showed the strongest affinity to LPS and it was the most potent peptide to 
cause disruption of the outer and cytoplasmic membrane. The two ostricacins showed 
stronger affinity than HNP-1 and they also indicated partial permeabilisation of the 
outer membrane and a slight depolarisation of the cytoplasmic membrane. HNP-1 did 
not indicate disruption of the outer membranes or depolarisation of the cytoplasmic 
membrane. Further invest igation indicated that the partial disruption allowed the 
ostricacins to pass through the membranes and interact with the intracellular 
components. However, these peptides could not inhibit the bacterial colony forming 
potential, and therefore, they were considered bacteriostatic . [t is recommended that 
further research be carried out to investigate the feasibility of ostricacins in adding value 
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